Stock Alert: Altimmune Loses 6%

By RTTNews Staff Write  ✉   | Published:

Shares of clinical-stage bio pharmaceutical company Altimmune, Inc. (ALT) are down more than 6% Thursday morning after the company said that the FDA has issued a clinical hold on the Investigational New Drug (IND) application for its Covid-19 vaccine candidate, AdCOVID.

The regulator asked the company for some protocol changes and also sought additional data on AdCOVID's chemistry, manufacturing and controls.

Altimmune said it has responded to the Agency's clinical hold letter received on December 22, 2020, does not see a significant impact on the overall clinical development timeline as the Company has agreed to each of the FDA's requests.

ALT, currently at $11.75, has been trading in the range of $1.60- $35.1 in the last one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Previous Story
Next Story
Editors Pick
Walmart Administers Its First Covid Vaccine In New Mexico
Walmart said it started administering its first COVID-19 vaccines to health care workers in the state of New Mexico. The retail giant said the recently approved Moderna vaccine was given to pharmacists at select Walmart stores and Sam's Clubs. The company is in discussions with other states to support their vaccine administration efforts.
SEC Chairman Jay Clayton Steps Down
Jay Clayton has resigned as chairman of the Securities and Exchange Commission on Wednesday. Clayton previously had said that he would step down by the end of the year. He began his tenure in May 2017.
CLS Gourmet Recalls Various Meat Products
CLS Gourmet CL Saigon Food Co. is recalling around 128,841 pounds of various meat products that were produced without the benefit of federal inspection, according to the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS. The recall involves around ten raw and fully cooked meat products that were produced and distributed between April 29, 2020 and December 5, 2020.